These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30673110)

  • 1. A Silent COL17A1 Variant Alters Splicing and Causes Junctional Epidermolysis Bullosa.
    Hoffmann J; Casetti F; Reimer A; Leppert J; Grüninger G; Has C
    Acta Derm Venereol; 2019 Apr; 99(4):460-461. PubMed ID: 30673110
    [No Abstract]   [Full Text] [Related]  

  • 2. Next generation sequencing identifies double homozygous mutations in two distinct genes (EXPH5 and COL17A1) in a patient with concomitant simplex and junctional epidermolysis bullosa.
    Vahidnezhad H; Youssefian L; Saeidian AH; Touati A; Sotoudeh S; Jazayeri A; Guy A; Lovell PA; Liu L; Kariminejad A; McGrath JA; Zeinali S; Uitto J
    Hum Mutat; 2018 Oct; 39(10):1349-1354. PubMed ID: 30016581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid duplication in the coiled-coil structure of collagen XVII alters its maturation and trimerization causing mild junctional epidermolysis bullosa.
    Kroeger JK; Hofmann SC; Leppert J; Has C; Franzke CW
    Hum Mol Genet; 2017 Feb; 26(3):479-488. PubMed ID: 28365758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Novel COL17A1 Compound Heterozygous Mutation in a Chinese Girl with Non-Herlitz Junctional Epidermolysis Bullosa.
    Yao YY; Zhang Y; Xie XH; Chen L; Zhu F; Zhou M
    Curr Med Sci; 2020 Aug; 40(4):795-800. PubMed ID: 32862392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New versatile monoclonal antibodies against type XVII collagen endodomain for diagnosis and subtyping COL17A1-associated junctional epidermolysis bullosa.
    Yuen WY; Di Zenzo G; Jonkman MF; Pas HH
    J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1426-7. PubMed ID: 26334130
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe phenotype of junctional epidermolysis bullosa generalised intermediate type caused by homozygous COL17A1:c.505C>T (p.Arg169*) mutation.
    Vaz SO; Dâmaso C; Liu L; Ozoemena L; Mota-Vieira L
    Eur J Dermatol; 2018 Jun; 28(3):412-413. PubMed ID: 29952287
    [No Abstract]   [Full Text] [Related]  

  • 7. Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa.
    Ablinger M; Lettner T; Friedl N; Potocki H; Palmetzhofer T; Koller U; Illmer J; Liemberger B; Hainzl S; Klausegger A; Reisenberger M; Lambert J; Van Gele M; Desmet E; Van Maelsaeke E; Wimmer M; Zauner R; Bauer JW; Wally V
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case of non-Herlitz junctional epidermolysis bullosa with COL17A1 mutation.
    Kasai H; Sasaki T; Matsuzaki H; Yoshioka T; Nagao K; Amagai M; Ishiko A; Kubo A
    J Dermatol; 2015 Mar; 42(3):323-5. PubMed ID: 25573436
    [No Abstract]   [Full Text] [Related]  

  • 9. Autosomal dominant junctional epidermolysis bullosa.
    Almaani N; Liu L; Dopping-Hepenstal PJ; Lovell PA; Lai-Cheong JE; Graham RM; Mellerio JE; McGrath JA
    Br J Dermatol; 2009 May; 160(5):1094-7. PubMed ID: 19120338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A de novo COL17A1 splice-site mutation causing a 7-bp deletion in a Taiwanese patient with junctional epidermolysis bullosa.
    Hou PC; Tu WT; Chen PC; Guevara BEK; Yen YF; Huang HY; Lee JY; Tang MJ; Kuo PL; Mcgrath JA; Hsu CK
    Eur J Dermatol; 2021 Apr; 31(2):267-269. PubMed ID: 34001479
    [No Abstract]   [Full Text] [Related]  

  • 11. Digenic junctional epidermolysis bullosa: mutations in COL17A1 and LAMB3 genes.
    Floeth M; Bruckner-Tuderman L
    Am J Hum Genet; 1999 Dec; 65(6):1530-7. PubMed ID: 10577906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localized and generalized forms of blistering in junctional epidermolysis bullosa due to COL17A1 mutations in the Netherlands.
    Pasmooij AM; Pas HH; Jansen GH; Lemmink HH; Jonkman MF
    Br J Dermatol; 2007 May; 156(5):861-70. PubMed ID: 17263807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategy for the Optimization of Read-Through Therapy for Junctional Epidermolysis Bullosa with COL17A1 Nonsense Mutation.
    Sayar SB; Has C
    J Invest Dermatol; 2024 Oct; 144(10):2221-2229.e1. PubMed ID: 38522573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid substitution in the C-terminal domain of collagen XVII reduces laminin-332 interaction causing mild skin fragility with atrophic scarring.
    Kroeger J; Hoppe E; Galiger C; Has C; Franzke CW
    Matrix Biol; 2019 Jul; 80():72-84. PubMed ID: 30316981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of phenotypic variability in junctional epidermolysis bullosa.
    Kiritsi D; Kern JS; Schumann H; Kohlhase J; Has C; Bruckner-Tuderman L
    J Med Genet; 2011 Jul; 48(7):450-7. PubMed ID: 21357940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-onset skin fragility in childhood: a case of junctional epidermolysis bullosa of late onset caused by a missense mutation in COL17A1.
    Vanotti S; Chiaverini C; Charlesworth A; Bonnet N; Berbis P; Meneguzzi G; Lacour JP
    Br J Dermatol; 2013 Sep; 169(3):714-5. PubMed ID: 23550562
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of junctional epidermolysis bullosa with prurigo-like lesions and reduction of collagen XVII and filaggrin.
    Cifuentes L; Kiritsi D; Chen W; Pennino J; Ring J; Weidinger S; Has C
    Br J Dermatol; 2013 Jul; 169(1):195-8. PubMed ID: 23834121
    [No Abstract]   [Full Text] [Related]  

  • 18. Gentamicin induces COL17A1 nonsense mutation readthrough in junctional epidermolysis bullosa.
    Li Y; Shen J; Liang J; Zheng L; Chen F; Yao Z; Li M
    J Dermatol; 2020 Mar; 47(3):e82-e83. PubMed ID: 31919892
    [No Abstract]   [Full Text] [Related]  

  • 19. The missense mutation p.R1303Q in type XVII collagen underlies junctional epidermolysis bullosa resembling Kindler syndrome.
    Has C; Kiritsi D; Mellerio JE; Franzke CW; Wedgeworth E; Tantcheva-Poor I; Kernland-Lang K; Itin P; Simpson MA; Dopping-Hepenstal PJ; Fujimoto W; McGrath JA; Bruckner-Tuderman L
    J Invest Dermatol; 2014 Mar; 134(3):845-849. PubMed ID: 24005051
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of the COL17A1 in non-Herlitz junctional epidermolysis bullosa and amelogenesis imperfecta.
    Nakamura H; Sawamura D; Goto M; Nakamura H; Kida M; Ariga T; Sakiyama Y; Tomizawa K; Mitsui H; Tamaki K; Shimizu H
    Int J Mol Med; 2006 Aug; 18(2):333-7. PubMed ID: 16820943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.